The functioning of PDE4, which presumably reduces the cAMP levels, is significant for attenuating the PKA signaling, and thus the inhibitors for PDE4 have been a therapeutic option to treat different CNS diseases, including memory impairment [11]. The gene discussed is PDE4A; the disease is memory impairment.